Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0.00962264150943393 0.00962264150943393 0.00962264150943393
Stock impact report

Acceleron Announces Second Quarter 2020 REBLOZYL® Net Sales

Acceleron Pharma, Inc (XLRN)  More Company Research Source: Business Wire
Last acceleron pharma, inc earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.acceleronpharma.com/investor-relations
PDF - Acceleron expects to report approximately $11.1 million in royalty revenue for Q2 2020 from approximately $55.0 million in net U.S. sales of REBLOZYL® (luspatercept-aamt) as reported by Bristol Myers Squibb -- Acceleron will report its full second quarter 2020 financial and operating results after the close of U.S. financial markets today, August 6, 2020, with its webcast and conference call starting at 5:00 p.m. EDT - CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (Nasdaq:XLRN), a biopharmaceutical company dedicated to the discovery, development, and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases, today announced net sales of REBLOZYL® (luspatercept-aamt) in the United States as reported by its global collaborator, Bristol Myers Squibb, were approximately $55.0 million for the second quarter ended June 30, 2020.Acceleron expects to report royalty revenue of approximately $11.1 million from net sales of REBLOZYL in the United S [Read more]
Impact snapshot Event time: XLRN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
XLRN alerts
from News Quantified
Opt-in for
XLRN alerts

from News Quantified
Opt-in for
XLRN alerts

from News Quantified